Why Myopia Matters
Currently, one-third of the American population has been diagnosed with myopia and it is expected that by 2050, 50% of our population will be myopic. In addition to common sense actions like reducing time indoors and in front of screens, we now have several options to treat myopia in children.
As myopia increases the risk for eye diseases increases, such as retinal detachment, myopic macular degeneration, glaucoma, and cataracts. The goal of myopia management is to slow eye growth and reduce the associated risks.
Myopia Treatments
Our team of optometrists are leaders in pediatric myopia control and use different therapies that have been studied and shown to slow myopia progression. We will spend some time to determine if a therapeutic course is best for your child. This is a limited overview. Please schedule an assessment or call our office for more information.
- Soft multifocal contact lenses: A specifically designed FDA approved myopia management soft contact lens, generally a disposable contact that is replaced daily.
- Orthokeratology (Ortho K): A specifically designed FDA approved lens that is worn overnight and removed in the morning which allows for NO correction to be worn during the day.
- Low dose atropine eye drops: An off-label use eye drop that is used nightly in each eye with a long history of clinical use.
- Spectacle lenses: Not yet available in the US. A new easy-to-fit non-invasive spectacle lens option currently under FDA review that fits standard eyegalss frames. If the maker acheives expected approval in the US, it will add a much needed non-invasive treatment option.
Take the Assessment
To start the conversation on your child's risk for myopia or the risk of progression, take this short survey. With only a few questions, it can help us estimate the level of risk of progressive myopia and what you can do to help them.
Powered by: 